M 14

Pill imprint M 14 has been identified as Methotrexate sodium 2.5 mg.

Methotrexate is used in the treatment of psoriasis; rheumatoid arthritis; brain tumor; breast cancer; ectopic pregnancy (and more), and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy.

Methotrexate 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.

Methotrexate sodium Images

Imprint:
M 14
Strength:
2.5 mg
Color:
Orange
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Inactive Ingredients:
silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
corn starch
sodium carbonate monohydrate
sodium lauryl sulfate
sodium starch glycolate type A potato
FD&C Red No. 40
Drug Class:
Antimetabolites
Antipsoriatics
Antirheumatics
Other immunosuppressants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0014
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0670 UDL Laboratories Inc
21695-0111 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Methotrexate sodium 2.5 mg M 14
Advertisement
Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

Did you find this page helpful? Yes No

(web6)